Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels.
about
Phase II study of topotecan and thalidomide in patients with high-risk myelodysplastic syndromes.Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancerCancer therapy: new targets for chemotherapy.A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia.
P2860
Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Treatment of refractory acute ...... with topoisomerase II levels.
@en
type
label
Treatment of refractory acute ...... with topoisomerase II levels.
@en
prefLabel
Treatment of refractory acute ...... with topoisomerase II levels.
@en
P2093
P2860
P1433
P1476
Treatment of refractory acute ...... with topoisomerase II levels.
@en
P2093
Fieniewicz KJ
Mainwaring MG
P2860
P304
P356
10.1080/10428190290021339
P577
2002-05-01T00:00:00Z